Professional Seasonal Analysis for Trading

Kiora Pharmaceuticals, Inc. - Common Stock (KPRX)

Seasonality Analysis

Stocks 12 Years Analyzed

Kiora Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

-49.53%
Avg Annual Return
34.9%
Avg Monthly Win Rate
4/12
Positive Months
12
Years Analyzed

Kiora Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -6.34%
45%
Weak
February -3.63%
33%
Very Weak
March WORST -14.63%
8%
Very Weak
April BEST 5.19%
50%
Weak
May -3.18%
45%
Weak
June -13.03%
27%
Very Weak
July -7.39%
27%
Very Weak
August -9.90%
27%
Very Weak
September 0.32%
55%
Moderate
October -4.54%
18%
Very Weak
November 5.02%
36%
Weak
December 2.58%
45%
Weak

Kiora Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
69.39
Historical Avg Position
43.69
Deviation
+25.7
Performance
Significantly Above Average

Kiora Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for KPRX with overlay patterns, custom date ranges, and more.

Create Free Account

Kiora Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Kiora Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for KPRX across multiple timeframes.

Create Free Account

About Kiora Pharmaceuticals, Inc. - Common Stock (KPRX) Seasonality

Kiora Pharmaceuticals, Inc. - Common Stock (KPRX) has been analyzed using 12 years of historical data to identify seasonal patterns. Classified under Stocks, Kiora Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Kiora Pharmaceuticals, Inc. - Common Stock is historically April, with an average return of 5.19% and a win rate of 50%. Conversely, March tends to be the weakest month, averaging -14.63% return.

Looking at the full calendar year, Kiora Pharmaceuticals, Inc. - Common Stock has an average annual return of -49.53% with an overall monthly win rate of 34.9%. Out of 12 months, 4 typically show positive average returns.

The seasonal pattern for Kiora Pharmaceuticals, Inc. - Common Stock has a consistency score of 71.2 (Very Good), based on 12 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Kiora Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Kiora Pharmaceuticals, Inc. - Common Stock (KPRX)?

Historically, April has been the best month for Kiora Pharmaceuticals, Inc. - Common Stock, with an average return of 5.19% and a win rate of 50%. However, past performance does not guarantee future results.

What is the worst month for Kiora Pharmaceuticals, Inc. - Common Stock (KPRX)?

Based on historical data, March has been the weakest month for Kiora Pharmaceuticals, Inc. - Common Stock, with an average return of -14.63%. This is a historical observation and does not guarantee future results.

How reliable is KPRX seasonality data?

The seasonality analysis for Kiora Pharmaceuticals, Inc. - Common Stock is based on 12 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Kiora Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Kiora Pharmaceuticals, Inc. - Common Stock (KPRX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.